What question did this study set out to answer?

This research aims to assess the mortality risk associated with femoral neck fractures (FNFs) over a four-year period.

March 30, 2026Open Access

Femoral neck fracture increases 30-day mortality 16-fold and elevates mortality risk for up to 4 years: a matched cohort study of 3,246 patients

PLP. LarsenAalborg University Hospital SJStefan Teglhus JensenAalborg University Hospital RERasmus Elsoe

Key Points

This research aims to assess the mortality risk associated with femoral neck fractures (FNFs) over a four-year period.
Matched cohort study based on registry data from the Danish National Patient Register
Included patients with FNFs and a reference population in a 1:10 ratio
Analyzed age, gender, and comorbidity status of all participants.
Patients with FNFs had a 30-day mortality rate of 10% compared to 0.3% in the matched cohort
Hazard ratio for 30-day mortality was 16.1
23.4% of patients died within the first 12 months, with elevated risk persisting for up to 4 years.

Abstract

Abstract Methods The study design was a matched cohort study based on prospectively collected registry data from the Danish National Patient Register. Included were all patients presenting with an FNF in the Northern Region of Denmark between 2018 and December 2023. The matched reference population was established with a 1:10 ratio (for each patient with an FNF, we included ten citizens who had not experienced an FNF prior to the inclusion date). Basic characteristics including age, gender, and individual comorbidity status were obtained from all patients and the matched population. Results A total of 3246 patients were identified with an FNF during the 6-year study period (mean follow-up 2.6 years). Patients’ mean age at the time of fracture was 77.9 (95% CI 77.4–78.4). Male mean age was 74.9 years (95% CI 73.9–75.9). Female mean age was 79.6 years (95% CI 79.1–80.2). Gender distribution was 64% females and 36% males. A total of 761 (23.4%) patients died during the first 12 months after the fracture. Within the first 30 days after fracture, patients with FNFs demonstrated markedly increased mortality compared with the age-, sex-, and comorbidity-matched reference cohort, with a crude 30-day mortality of 10% versus 0.3% and a hazard ratio of 16.1. Cumulative survival curves showed that patients with FNFs had an elevated mortality risk during the first 4 years following fracture, after which survival became nearly comparable between the fracture and matched cohorts. Conclusion This study demonstrated that FNFs are associated with a markedly elevated short-term mortality risk, with patients experiencing a 16 times higher risk of death within 30 days compared with an age-, gender-, and comorbidity-matched group without an FNF. The excess risk was most pronounced during the first 3–6 months and persisted for up to 4 years before converging with the match group mortality rates.

KI fragen

Bookmark

View Full Paper

Cite This Study

Larsen et al. (Sat,) studied this question.

synapsesocial.com/papers/69c9c57ff8fdd13afe0bd66b https://doi.org/https://doi.org/10.1007/s41999-026-01449-3

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

KI fragen

Bookmark

View Full Paper